FotiosKoumpourasMD

Director Yale Lupus Program

Dr. Koumpouras is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Yale-New Haven Medical CenterFellowship, Rheumatology, 2004 - 2007
Stony Brook Medicine/University HospitalResidency, Internal Medicine, 2000 - 2003
St. George's University School of MedicineClass of 2000

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Fellow (FACR) American College of Rheumatology

PubMed

28 citations
High-throughput identification of autoantibodies that target the human exoproteome.
Eric Y Wang, Yile Dai, Connor E Rosen, Monica M Schmitt, Mei X Dong
Cell Reports Methods. 2022-02-28
28 citations
Type I Interferon-Activated STAT4 Regulation of Follicular Helper T Cell-Dependent Cytokine and Immunoglobulin Production in Lupus.
Xuemei Dong, Olivia Q. Antao, Wenzhi Song, Gina M. Sanchez, Krzysztof Zembrzuski
Arthritis & Rheumatology. 2021-03-01
9 citations
IL-7 receptor alpha defines heterogeneity and signature of human effector memory CD8+ T cells in high dimensional analysis
Min Sun Shin, Dong-Joo Kim, Kristina Yim, Hong-Jai Park, Sungyong You
Cellular Immunology. 2020-06-24

Journal Articles

Chimeric antigen receptors: “CARs” in the fast lane for rheumatology
Nathan Johnson and Fotios Koumpouras, Current Opinion in Rheumatology, 5/2024

'The future is bright.' Yale doctor helps to advance the fight against lupusMarch 7th, 2024
New Cell Therapy Program to Offer Hope for Patients with Severe LupusJune 14th, 2023
Two for OneJune 17th, 2024
Join now to see all